Clinical Trial Update: R61/33 - VR Study Phase 4 [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for a VR-based study on Attention Deficit Hyperactivity Disorder, sponsored by Rutgers, The State University of New Jers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: RECRUITING